SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-10-28

Wed, Oct 28, 2026 - Page 143

28148 indexed SquawkNews stories from this UTC day. Showing 17041-17160.

EQUITY 18049EARNINGS 3871MACRO 1303REGULATION 1292CENTRAL_BANK 711RATES 544ENERGY 469GEOPOLITICS 442MNA 394NEWS 336COMMODITIES 317FX 296
L Exel Composites updates financial calendar Exel Composites says it will publish its January–September 2026 results. EQUITY | Oct 28, 2026, 11:06 AM UTC L Exel Composites Updates Financial Calendar Exel Composites Oyj published an update to its financial calendar. EQUITY | Oct 28, 2026, 11:06 AM UTC M Accuray Q1'27 Results Scheduled for November 4 Accuray is scheduled to report Q1'27 results on November 4 after the market closes. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:06 AM UTC M Penske Q3 Revenue Reaches $8,415.6 Million Penske reported Q3 revenue of USD 8,415.6 million, versus an IBES estimate of USD 8,171 million. EQUITY | Oct 28, 2026, 11:06 AM UTC L BCE pode acalmar apostas sobre juros, mas talvez ainda não queira CENTRAL_BANK | Oct 28, 2026, 11:06 AM UTC L Monte Rosa Therapeutics Eligible for Up to $2.10 Billion in Milestones EQUITY | Oct 28, 2026, 11:06 AM UTC L Sampo Updates Financial Calendar Sampo says it will publish January results. EQUITY | Oct 28, 2026, 11:06 AM UTC L Initiator Pharma Completes Dosing in Phase 2a Vulvodynia Study Initiator Pharma said dosing is complete in its Phase 2a study of pudafensine for vulvodynia. EQUITY | Oct 28, 2026, 11:06 AM UTC M Biote Corp. Q3'26 Earnings Preview: Revenue Estimated at 44.01 Million USD Biote Corp. is scheduled to report Q3'26 results on November 04 after the market close. Revenue is estimated at 44.01 million USD and EPS at (0.01) USD. EQUITY | Oct 28, 2026, 11:06 AM UTC M Townsquare Media Q3'26 Earnings Preview Townsquare Media is scheduled to report Q3'26 results on November 4 before the market opens. EQUITY | Oct 28, 2026, 11:06 AM UTC M Neumora Therapeutics Q3'26 Earnings Scheduled for Nov. 4 Neumora Therapeutics is set to report Q3'26 results on November 4. Revenue and EPS estimates are stated in the source; the release time is not specified. EQUITY | Oct 28, 2026, 11:06 AM UTC H INVE Q3'26 Earnings: revenue estimate is 4.45M USD INVE (INVE Technologies, Inc.) is set to announce its Q3'26 results on November 04, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 4.45 million U EARNINGS | Oct 28, 2026, 11:06 AM UTC M Clipper Realty Q3'26 Revenue Estimate Is 38.70M USD Clipper Realty is scheduled to report Q3'26 results on November 04 before the market opens. Revenue is estimated at 38.70 million USD. EQUITY | Oct 28, 2026, 11:06 AM UTC L Initiator Pharma Completes Dosing in Phase 2a Vulvodynia Trial Initiator Pharma completed dosing in its Phase 2a pudafensine trial for vulvodynia. EQUITY | Oct 28, 2026, 11:06 AM UTC L Bausch & Lomb files Form 8-K Bausch & Lomb filed a Form 8-K on October 28. EQUITY | Oct 28, 2026, 11:06 AM UTC M CPS Technologies Q3'26 Results Expected November 4 CPS Technologies is scheduled to report Q3'26 results before the market opens on November 4. EQUITY | Oct 28, 2026, 11:06 AM UTC L ECB May Temper Rate Expectations, Mike Dolan Says Mike Dolan says the ECB could temper rate expectations, but may not yet want to do so. CENTRAL_BANK | Oct 28, 2026, 11:06 AM UTC H Spain High-Speed Train Collision Kills 30 A high-speed train collision in Spain killed 30 people, Reuters reported. MACRO | Oct 28, 2026, 11:06 AM UTC M SelectQuote Q1'27 Earnings Preview SelectQuote is scheduled to report Q1'27 results on November 04 before the market opens. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:06 AM UTC L Sampo Updates Financial Calendar Sampo will publish its January-September 2026 results. EQUITY | Oct 28, 2026, 11:06 AM UTC M ARQ Q3'26 Earnings Estimates Ahead of Scheduled Results Arq, Inc. is scheduled to report Q3'26 results on November 4 after the market close. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:06 AM UTC L Baker Hughes Books Contract Award in Q3 2026 EQUITY | Oct 28, 2026, 11:06 AM UTC M Regis Q1'27 Results Due November 4 Regis is expected to report Q1'27 results on November 4; the release time is not specified. EQUITY | Oct 28, 2026, 11:06 AM UTC M Sera Prognostics Q3'26 Results Preview: Revenue Estimate Is 75.00K USD Sera Prognostics is scheduled to report Q3'26 results on November 4 after the market close. Revenue is estimated at 75.00 thousand USD and EPS at (0.14) USD. EQUITY | Oct 28, 2026, 11:06 AM UTC L BCE may curb rate expectations but may not yet want to act Mike Dolan says the European Central Bank could temper expectations about interest rates, though it may not yet be ready to do so. CENTRAL_BANK | Oct 28, 2026, 11:06 AM UTC L Sampo Updates Financial Calendar Sampo published an update to its financial calendar. The body is truncated and provides no further details. EQUITY | Oct 28, 2026, 11:06 AM UTC L UPM sets October 31 for WISA Group separation UPM has decided to complete the separation of WISA Group on October 31. EQUITY | Oct 28, 2026, 11:06 AM UTC M Tigo Energy Q3'26 Results Due Nov. 4 Tigo Energy is scheduled to report Q3'26 results on Nov. 4. The release time is not specified. EQUITY | Oct 28, 2026, 11:06 AM UTC L Euronext Dublin Issues GEM Cancellation Notice Euronext Dublin published a GEM cancellation notice. EQUITY | Oct 28, 2026, 11:06 AM UTC M Outset Medical Q3'26 Revenue Estimate Is 31.40M USD Outset Medical is scheduled to report Q3'26 results on November 4 after the market closes. EPS is anticipated at (0.69) USD. EQUITY | Oct 28, 2026, 11:06 AM UTC L Minerva Neurosciences to Host Expert Event on Roluperidone Minerva Neurosciences will host an expert event about roluperidone for schizophrenia’s negative symptoms. EQUITY | Oct 28, 2026, 11:06 AM UTC M Stabilis Solutions Q3 Earnings Preview Lists Revenue Estimate Stabilis Solutions is scheduled to report Q3 results on November 4 after the market closes. Revenue and EPS estimates are provided in the source. EQUITY | Oct 28, 2026, 11:06 AM UTC L ECB may be unwilling to curb rate expectations for now Reuters columnist Mike Dolan says the ECB could curb rate expectations but may not intend to do so at present. CENTRAL_BANK | Oct 28, 2026, 11:06 AM UTC M AKA Q3’26 Earnings Preview AKA (a.k.a. Brands Holding Corp.) is scheduled to report Q3’26 results on November 4 after the market close. Revenue and EPS estimates are provided in the source. EQUITY | Oct 28, 2026, 11:06 AM UTC M Inseego Q3'26 Results Due November 4 Inseego is scheduled to report Q3'26 results after the market closes on November 4. EPS is estimated at $(0.33). EQUITY | Oct 28, 2026, 11:06 AM UTC M Zevia Q3 Revenue Estimate Ahead of Scheduled Results Zevia PBC is scheduled to report Q3 results after the market closes on November 04. Revenue is estimated and EPS is anticipated; the source gives no supported values. EQUITY | Oct 28, 2026, 11:06 AM UTC L Alvotech Updates Financial Calendar Alvotech will release its third-quarter and nine-month results. EQUITY | Oct 28, 2026, 11:06 AM UTC M IEIT Systems Q3 Net Profit Rises 43.46% Year Over Year EQUITY | Oct 28, 2026, 11:06 AM UTC L BCE Could Temper Rate Expectations, but Perhaps Not Yet Mike Dolan's commentary considers whether the European Central Bank could temper rate expectations, while suggesting the timing may not yet be right. CENTRAL_BANK | Oct 28, 2026, 11:06 AM UTC M BHR Q3'26 Earnings Preview: Revenue Estimate Released Braemar Hotels & Resorts is scheduled to report Q3'26 results on November 4 after the market closes. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:06 AM UTC M Unifi Q1'27 Earnings Preview: Revenue Estimate Unifi is scheduled to report Q1'27 results on November 4; EPS is anticipated at $(0.15). EQUITY | Oct 28, 2026, 11:06 AM UTC H MGNX Q3'26 Earnings: revenue estimate is 39.18M USD MGNX (MacroGenics, Inc.) is set to announce its Q3'26 results on November 04, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 39.18 million USD wi EARNINGS | Oct 28, 2026, 11:06 AM UTC M Beyond Meat Q3 Earnings Preview: Revenue Estimated at 62.00M USD Beyond Meat is scheduled to report Q3'26 results on November 04 after the market closes. Revenue is estimated at 62.00 million USD and EPS at (1.97) USD. EQUITY | Oct 28, 2026, 11:06 AM UTC L FDA authorizes clinical trial of United Therapeutics’ Treprostinil-Iloprost SMI The FDA authorized a clinical trial of United Therapeutics’ Treprostinil-Iloprost SMI. REGULATION | Oct 28, 2026, 11:06 AM UTC M Caesarstone Q3'26 Results Expected November 04 Caesarstone is scheduled to report Q3'26 results before the market opens on November 04. Revenue is estimated at 105.20 million USD and EPS at (0.16) USD. EQUITY | Oct 28, 2026, 11:06 AM UTC M Magnachip Q3'26 Earnings Estimates Ahead of November 4 Release Magnachip is scheduled to report Q3'26 results on November 4 after the market closes. The source lists revenue and EPS estimates. EQUITY | Oct 28, 2026, 11:06 AM UTC M Traeger Q3'26 Earnings Preview Includes Revenue Estimate Traeger is scheduled to report Q3'26 results on November 4 after the market close. EPS is estimated at $(4.54). EQUITY | Oct 28, 2026, 11:06 AM UTC M Processa Pharmaceuticals Q3'26 Earnings Preview: EPS Estimate at (1.00) USD Processa Pharmaceuticals is scheduled to report Q3'26 results on October 29. EPS is anticipated at (1.00) USD; the report time is not specified. EQUITY | Oct 28, 2026, 11:06 AM UTC M Chefs' Warehouse Reports Q3 Adjusted EPS of $0.66 Chefs' Warehouse Q3 adjusted EPS was $0.66, versus the IBES estimate of $0.56. EARNINGS | Oct 28, 2026, 11:06 AM UTC M Littelfuse reports Q3 sales of USD 766.729 million EARNINGS | Oct 28, 2026, 11:06 AM UTC M Cytosorbents Q3'26 Earnings Preview Includes EPS Estimate of (0.90) USD Cytosorbents is set to report Q3'26 results on October 29; the release time is not specified. EPS is expected at (0.90) USD. EQUITY | Oct 28, 2026, 11:05 AM UTC L Kirby reports Q3 EPS of USD 2.09 Kirby reported Q3 net income of USD 110.8 million. The supplied report truncates before giving revenue. EARNINGS | Oct 28, 2026, 11:05 AM UTC M ACR Q3'26 Earnings Preview ACRES Commercial Realty is scheduled to report Q3'26 results on November 4 after the market closes. EQUITY | Oct 28, 2026, 11:05 AM UTC M Cellectar Biosciences Q3'26 Results Due October 29; EPS Estimate Is (0.56) USD The company is expected to report Q3'26 results on October 29. Revenue is estimated at 0 USD, with EPS expected at (0.56) USD; the release time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Hayward Holdings Q3 Adjusted EBITDA $64.5 Million vs. IBES Estimate $58.6 Million EARNINGS | Oct 28, 2026, 11:05 AM UTC L Volkswagen Plans to Globalize Technology Developed in China EQUITY | Oct 28, 2026, 11:05 AM UTC M Karyopharm Therapeutics Q3 Results Preview: EPS Estimate at $(0.95) Karyopharm Therapeutics is scheduled to report Q3'26 results on October 29. EPS is estimated at $(0.95); the release time is unspecified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Monte Rosa to Receive $37.5 Million Novartis Milestone Payment Monte Rosa Therapeutics said it will receive a $37.50 million milestone payment from Novartis for the first patient visit. EQUITY | Oct 28, 2026, 11:05 AM UTC L Baker Hughes Wins Subsea Systems Award for Eni’s Cronos Gas Development Baker Hughes won an award to provide subsea production systems and services for Eni’s Cronos gas development. EQUITY | Oct 28, 2026, 11:05 AM UTC L Thermal Energy Announces $2 Million Heat Recovery Project Thermal Energy says it secured a $2 million turnkey heat recovery project with a global nutrition company. EQUITY | Oct 28, 2026, 11:05 AM UTC M Red Robin Q3'26 Revenue Estimated at 251.67M USD Red Robin is scheduled to report Q3'26 results on November 04 after market close. Revenue is estimated at 251.67 million USD and EPS at (0.36) USD. EQUITY | Oct 28, 2026, 11:05 AM UTC L Monte Rosa Therapeutics to Receive Milestone Payment Monte Rosa Therapeutics says it will receive a milestone payment upon the first patient visit in a Phase 2 study. EQUITY | Oct 28, 2026, 11:05 AM UTC M Neuronetics Q3 Results Expected November 4; Revenue Estimate Reported Neuronetics is scheduled to report Q3'26 results before the market opens on November 4. Revenue is estimated, with EPS anticipated at $(0.09). EQUITY | Oct 28, 2026, 11:05 AM UTC M Bionano Genomics Q3'26 Earnings Preview Lists EPS Estimate Bionano Genomics is expected to report Q3'26 results on October 29; the release time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC L Ripley PR Named Agency of the Year by Prestige Awards Prestige Awards recognized Ripley PR as Agency of the Year. EQUITY | Oct 28, 2026, 11:05 AM UTC M NextCure Q3'26 Earnings Preview: EPS Estimate at (0.90) USD NextCure is scheduled to report Q3'26 results on October 29; the release time is not specified. Revenue is estimated at 0 USD and EPS at (0.90) USD. EQUITY | Oct 28, 2026, 11:05 AM UTC M Stoneridge Q3 Earnings Preview Stoneridge is scheduled to report Q3'26 results on November 4 after the market closes. Revenue and EPS estimates were included in the source but are omitted here. EQUITY | Oct 28, 2026, 11:05 AM UTC M NAGE Q3'26 Earnings Preview: Revenue Estimate Niagen Bioscience is set to report Q3'26 results November 4 after the market closes. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:05 AM UTC M TPVG Q3'26 Earnings Preview TPVG is expected to report Q3'26 results on November 4 after the market closes. EQUITY | Oct 28, 2026, 11:05 AM UTC M Thryv Q3'26 Earnings Preview: EPS Estimate at (0.16) USD Thryv is scheduled to report Q3'26 results on October 29. EPS is anticipated at (0.16) USD. The release time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Softlab360 Joins The Wealth Mosaic, Adds Strategic Partnership Exec, Earns Luminaries Recognition CEO Henry Zelikovsky to join the "Buy, Build, Rent" panel at Nasdaq MarketSite November 2nd NEW YORK EQUITY | Oct 28, 2026, 11:05 AM UTC L ServiceForge Launches ‘Keep Service Human’ Podcast Hosted by ServiceForge’s Jane Blanchard, the podcast will explore relationships and authenticity in the skilled trades. EQUITY | Oct 28, 2026, 11:05 AM UTC L Temasek Life Sciences Files Form 13F-NT A Form 13F-NT for Temasek Life Sciences covering the period ended September 30 was filed. EQUITY | Oct 28, 2026, 11:05 AM UTC M Unisys Q3'26 Revenue Estimate Ahead of Results Unisys is scheduled to report Q3'26 results on November 4 after the market closes. EPS is anticipated at $(0.21). EQUITY | Oct 28, 2026, 11:05 AM UTC L Oatly Group files Form 6-K for period ended Sept. 30 Oatly Group AB filed a Form 6-K for the period ended September 30. EQUITY | Oct 28, 2026, 11:05 AM UTC M Cable One Q3'26 Earnings Preview Lists EPS Estimate of 4.40 USD Cable One is set to report Q3'26 results on October 29; the release time is not specified. Revenue is estimated at 342.06 million USD and EPS at 4.40 USD. EQUITY | Oct 28, 2026, 11:05 AM UTC M Altisource Portfolio Solutions Q3'26 Earnings Preview Altisource Portfolio Solutions is scheduled to report Q3'26 results on October 29 before the market opens. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:05 AM UTC M Sensus Healthcare Q3 Results Expected October 29 Sensus Healthcare is scheduled to report Q3'26 results on October 29. EPS is estimated at $(0.06); the report time is unspecified. EQUITY | Oct 28, 2026, 11:05 AM UTC M OFS Q3'26 Results Due October 29 After Market Close OFS Capital Corporation is expected to report Q3'26 results at 4:00 p.m. ET on October 29. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:05 AM UTC L Aebi Schmidt Declares Quarterly Dividend of $0.025 Per Share Aebi Schmidt declared a quarterly dividend of $0.025 per share. EQUITY | Oct 28, 2026, 11:05 AM UTC L Volkswagen Plans Strategy Shift to Take China-Developed Technologies Global Volkswagen plans to introduce technologies developed in China worldwide as part of a strategy change. EQUITY | Oct 28, 2026, 11:05 AM UTC M CarParts.com Q3'26 Results Due October 29; EPS Estimate at $(0.83) CarParts.com is scheduled to report Q3'26 results after the market closes on October 29. EPS is estimated at $(0.83). EQUITY | Oct 28, 2026, 11:05 AM UTC L Genprex files Form 8-K Genprex filed a Form 8-K on October 28. EQUITY | Oct 28, 2026, 11:05 AM UTC M GECC Q3'26 Earnings Preview Includes EPS Estimate GECC is scheduled to report Q3'26 results on October 29; estimated revenue and EPS were provided. The report time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Universal Electronics Q3'26 Earnings Preview Universal Electronics is scheduled to report Q3'26 results on October 29. The release time is unspecified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Atara Biotherapeutics Q3 Earnings Preview: EPS Estimate at (0.13) USD Atara Biotherapeutics is set to report Q3'26 results on October 29. Revenue is estimated at 800.00 thousand USD and EPS at (0.13) USD; the release time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Franklin Covey Q4'26 Earnings Preview Franklin Covey is scheduled to report Q4'26 results on November 4 after the market closes. EQUITY | Oct 28, 2026, 11:05 AM UTC L Areo Holdings Files Schedule 13G/A for Sunlands Technology Group A Schedule 13G/A for Sunlands Technology Group was filed by Areo Holdings Ltd. The filing date is listed as October 28, 20. EQUITY | Oct 28, 2026, 11:05 AM UTC M ECOR Q3'26 Earnings Preview: EPS Estimated at (0.27) USD ECOR is expected to report Q3'26 results on October 29; the release time is not specified. EPS is estimated at (0.27) USD. EQUITY | Oct 28, 2026, 11:05 AM UTC M CRDF Q3'26 Earnings Preview Gives EPS Estimate of (0.14) USD Cardiff Oncology is scheduled to report Q3'26 results on October 29; the release time is not specified. Revenue is estimated at 81.43 thousand USD, with EPS anticipated at (0.14) USD. EQUITY | Oct 28, 2026, 11:05 AM UTC L Masco files Form 8-K Masco filed a Form 8-K on October 28. EQUITY | Oct 28, 2026, 11:05 AM UTC L Exel Composites schedules Q3 2026 briefing for 4 November Exel Composites invited investors to a briefing on its third-quarter 2026 results on 4 November. EQUITY | Oct 28, 2026, 11:05 AM UTC L Hansa Biopharma Updates Financial Calendar Hansa Biopharma will publish its January–September 20 financial results. EQUITY | Oct 28, 2026, 11:05 AM UTC L Temasek Capital files Form 13F-NT for September 30 A Form 13F-NT for Temasek Capital is listed for September 30. The filing date is truncated in the source. EQUITY | Oct 28, 2026, 11:05 AM UTC M LENZ Q3'26 Earnings Preview: EPS Estimate at (0.89) USD LENZ Therapeutics is scheduled to report Q3'26 results on October 29 before the market opens. EPS is anticipated at (0.89) USD. EQUITY | Oct 28, 2026, 11:05 AM UTC M Immunic Q3'26 Results Due October 29; EPS Estimate Is $(0.93) Immunic is set to report Q3'26 results on October 29; the release time is unspecified. EPS is estimated at $(0.93). EQUITY | Oct 28, 2026, 11:05 AM UTC L Urban Edge Properties Files Form 10-Q for Quarter Ended September 30 Urban Edge Properties filed a Form 10-Q covering the period ended September 30. The filing date is listed as October 28; no year is provided. EQUITY | Oct 28, 2026, 11:05 AM UTC L IDEX Corp. files Form 8-K IDEX Corp. filed a Form 8-K on October 28. EQUITY | Oct 28, 2026, 11:05 AM UTC M DHI Group Set to Report Q3 Results November 4 DHI Group is scheduled to announce Q3'26 results after the market closes on November 4. EQUITY | Oct 28, 2026, 11:05 AM UTC M NATR Q3'26 Earnings Preview Nature's Sunshine Products is scheduled to report Q3'26 results on November 4 after the market close. EQUITY | Oct 28, 2026, 11:05 AM UTC M FGBI Q3'26 Earnings Preview: EPS Estimate First Guaranty Bancshares is scheduled to report Q3'26 results on October 29; the release time is unspecified. An EPS estimate is provided. EQUITY | Oct 28, 2026, 11:05 AM UTC M Atomera Q3 Earnings Preview: EPS Estimate Reported Atomera is scheduled to report Q3 results on October 29 after the market closes. Revenue and EPS estimates are provided in the source. EQUITY | Oct 28, 2026, 11:05 AM UTC L EnerSys Files SC TO-T Form for Ultralife A Schedule TO-T filing names Ultralife Corp. and was filed by EnerSys. MNA | Oct 28, 2026, 11:05 AM UTC L Diebold Nixdorf Authorizes New $250 Million Share Repurchase Program The company said its previous $200 million repurchase program is nearly complete. EQUITY | Oct 28, 2026, 11:05 AM UTC L Garmin files Form 10-Q for period ended Sept. 26 Garmin filed a Form 10-Q covering the period ended Sept. 26. EQUITY | Oct 28, 2026, 11:05 AM UTC M Silvaco Group Q3’26 Earnings Preview Silvaco Group is scheduled to report Q3’26 results on November 4 after the market closes. EQUITY | Oct 28, 2026, 11:05 AM UTC M Protara Therapeutics Q3 Results Due October 29; EPS Estimate $(0.37) Protara Therapeutics is expected to report Q3'26 results on October 29. EPS is forecast at $(0.37); the release time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC M SMHI Q3'26 Earnings Preview: Revenue Estimate SMHI is set to report Q3'26 results on November 4. EPS is anticipated at $(0.61); results are expected at 7:00 a.m. ET (12:00 p.m. UTC). EQUITY | Oct 28, 2026, 11:05 AM UTC M Codexis Q3'26 earnings preview cites EPS estimate of $(0.10) Codexis is scheduled to announce Q3'26 results on October 29, with EPS expected at $(0.10). EQUITY | Oct 28, 2026, 11:05 AM UTC M MBI Q3'26 Earnings Preview MBIA is scheduled to report Q3'26 results on November 4 after the market close. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:05 AM UTC M Akebia Therapeutics Q3'26 Earnings Preview: EPS Estimate at $(0.04) Akebia Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is estimated at $(0.04). EQUITY | Oct 28, 2026, 11:05 AM UTC M Optimum Communications Q3 Revenue Estimate Ahead of Earnings Optimum Communications is scheduled to announce Q3'26 results on November 4; revenue is estimated at 1.99 billion USD and EPS at (0.18) USD. The release time is not specified. EQUITY | Oct 28, 2026, 11:05 AM UTC M SmartRent Q3'26 Earnings Preview SmartRent is scheduled to report Q3'26 results on November 4 before the market opens. Revenue and EPS estimates were provided, without reproducing their values. EQUITY | Oct 28, 2026, 11:05 AM UTC M Pro-Dex Q1'27 Earnings Preview Lists EPS Estimate Pro-Dex is scheduled to report Q1'27 results on October 29. Revenue and EPS estimates were provided; the report time is unspecified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Digimarc Q3'26 Earnings Preview Lists an EPS Loss Estimate Digimarc is scheduled to report Q3'26 results on October 29. Revenue and EPS estimates were provided; the report time is unspecified. EQUITY | Oct 28, 2026, 11:05 AM UTC M Forrester Q3'26 earnings preview cites EPS estimate Forrester is scheduled to report Q3'26 results after the market closes on October 29. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:05 AM UTC M Xperi Q3'26 Results Due November 4 Xperi is set to report after the market closes. Revenue and EPS estimates were provided. EQUITY | Oct 28, 2026, 11:05 AM UTC M Hansa Biopharma to Host Q3 2026 Interim Results Call Hansa Biopharma said it will host a conference call on its Q3 2026 interim results. EQUITY | Oct 28, 2026, 11:05 AM UTC L Pomerantz Reminds Endava Shareholders of Class Action Lawsuit Pomerantz LLP issued a reminder to Endava Plc shareholders concerning a class action lawsuit. REGULATION | Oct 28, 2026, 11:05 AM UTC M Masco Q3 Adjusted EPS $1.19 vs. IBES Estimate $1.03 EARNINGS | Oct 28, 2026, 11:05 AM UTC